Revenue Growth Driven by Organic Demand
Net sales increased 2.7% year-over-year to $4.16B in Q1 2026 (vs. $4.05B in Q1 2025), suggesting continued consumer demand for KMB's personal care and tissue products despite a challenging macro environment.
KIMBERLY CLARK CORP is expected to release its Q2 2026 10-Q filing in the upcoming earnings season. Last quarter: Kimberly-Clark (KMB) delivered a strong Q1 2026 with revenue up 2.7% to $4.16B, operating income surging 19.3% to $753M, and operating cash flow more than doubling to $745M, reflecting improved operational efficiency despite modest gross margin compression.
Drawn from management commentary in the Q1 2026 10-Q:
Net sales increased 2.7% year-over-year to $4.16B in Q1 2026 (vs. $4.05B in Q1 2025), suggesting continued consumer demand for KMB's personal care and tissue products despite a challenging macro environment.
Operating income jumped 19.3% to $753M, with operating margin expanding approximately 252 basis points to 18.1% from 15.6%, indicating meaningful cost discipline and operational efficiency improvements beyond simple revenue growth.
Gross margin declined slightly by approximately 37 basis points to 36.8% (from 37.2%), as cost of revenue grew 3.3%—faster than revenue growth of 2.7%—suggesting input cost or mix headwinds at the product level.
Revenue
$4.16B
++2.69% YoY
EPS (Basic)
$2.00
++16.96% YoY
Gross Margin
36.8%
-0.37% YoY
Operating Income
$753M
++19.33% YoY
Add KMB to your watchlist to get the AI analysis in your inbox within minutes of the 10-Q filing.